Abstract
The in vitro sensitivity (minimum inhibitory concentrations; MICs) of 42 environmental isolates of pathogenic dematiaceous fungi to 7 azole compounds, viz. thiabendazole, ketoconazole, miconazole, econazole bifonazole, Bay n 7133, Bay 1 9139 and phenylpropyl-morpholine derivative, Ro14-4767/002 was studied by an agar dilution method using Emmon's Sabouraud dextrose agar (ESDA) as the culture medium.
The isolates of Fonsecaea pedrosoi, Cladosporium carrionii, Exophiala jeanselmei and Ramichloridium subulatum were most sensitive to bifonazole with mean MICs of 0.06 μg/ml or less; Phialophora verrucosa had an MIC of 0.05 μg/ml to ketoconazola and Ro14-4767/002, respectively. Ochroconis sp had an MIC of 0.025 μg/ml to Ro14-4767/002 and Cladosporium tennuisimum 0.39 μg/ml to ketoconazole. Econazole and thiabendazole also showed good antifungal activity. The fungi were relatively resistant to the more recently developed azoles, viz. Bay n 7133 and Bay 1 9139, the later failing to inhibit C. tennuisimum at a concentration of 100 μg/ml. The minimum fungicidal concentrations (MFC) of the drugs wree mostly within 2 to 8 fold of the MICs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arosemena RY, Saenz RE. 2 casos de cromomicosis tratados con 5-fluorocytosina. Revista Medica de Panama, 1976; 176:40–44.
Bayles MAH. Chromomycosis; treatment with thiabendazole. Arch Dermatol 1971; 104:476–485.
Corrado ML, Weitzman I, Stanek A, Goetz R, Agyare E. Subcutaneous infection with Phialophora richardsiae and its susceptibility to 5-fluorocytosine, Amphotericin B and Miconazole. Sabouraudia 1980; 18:97–104.
Corrado ML, Kramer M, Cummings M, Eng RH. Susceptibility of dematiaceous fungi to amphotericin B, miconazole, ketoconazole and rifampin alone and in combination. Sabouraudia 1982; 20:109–113.
Cuce LC, Wroclawski EL, Sampaio SA. Treatment of paracoccidioidomycosis, candidiasis, chromomycosis and mycetomas with ketoconazole. Int J Dermatol 1980; 19:405–408.
Drouhet E, Dupont E. Preliminary studies on the pharmacology and therapeutic activity of oral and intravenous econazole. Mykosen 1978; 1:192–201.
Fromtling RA, Yu H, Shadomy S. In vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and Bay 1 9139. Sabouraudia 1983; 21:179–184.
Gugnani, HC, Egere JU, Suseelan AV, Okoro AN, Onuigbo WIB. Chromomycosis caused by Phialophora pedrosoi in Eastern Nigeria. J Trop Med Hyg 1978; 81:208–210.
Haller I. The mode of action of imidazole antimycotics: Implications for sensitivity testing. Mykosen 1979; 2:423–430.
Hanifin JM. Ketoconazole, an oral antifungal with activity against superficial and deep mycoses. J Am Acad Dermatol 1980; 2:537–539.
Hoeprich PD, Huston AC. Effect of culture media on the antifungal activity of miconazole and amphotericin B mehtyl ester. J Inf Dis 1976; 134:336–341.
Lopes CF, Alvarenga RJ, Cisalpino EO, DeResende MA, Oliveira LG. 6 years of experience in the treatment of chromomycosis with 5-fluorocytosine. Int J Dermatol 1978; 17:414–418.
McBurney EI. Chromomycosis due to Fonsecaea pedrosoi: treatment with ketoconazole. Cutis 1982; 30:746–748.
McGinnis MR. Dematiaceous fungi in Manual of Clinical Microbiology, 3rd ed. Ed. Lennette EH, Balows A, Hausler WJ, Truant JP, eds. Washington: American Society for Microbiology 1980; 602–603.
McGinnis MR. Laboratory Handbook of Medical Mycology 1st ed. New York: Academic Press, 1980.
Mittag H, Kreysel HW. Clinical features, diagnosis and therapy of chromomycosis. Mykosen 1982; 25:413–423.
Olle-Goig JE, Domingo J. A case of chromomycosis treated with thiabendazole. Trans Roy Soc Trop Med Hyg 1983; 77:773–774.
Plempel M, Regel E, Buchel KH. Antimycotic efficacy of bifonazole in vitro and in vivo. Drug Res 1983; 33:517–524.
Polak A. Antifungal activity in vitro of Ro14-4767/002, a phenyl-propyl-morpholine. Sabouraudia 1983; 21:205–213.
Shadomy S, Espinel-Ingroff A, Kerkering TM. In vitro studies with 4 new antifungal agents: Bay n 7133, bifonazole (Bay h 4502), ICI 153,066 and Ro14-4767/002. Sabouraudia 1984; 22:7–15.
Shadomy S, Paxton L, Espinel-Ingroff A, Shadomy HJ. In vitro studies with miconazole and miconazole nitrate. J Antimicrob Chemother 1977; 3:147–152.
Whiting DA. Treatment of chromoblastomycosis with high local concentration of amphotericin B Brit J Dermatol 1967; 79:345–351.
Yamaguchi H, Hiratani T, Plempel M. In vitro studies of a new imidazole antimycotic, bifonazole in comparison with clotrimazole and miconazole. Drug Res 1983; 33:546–551.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okeke, C.N., Gugnani, H.C. In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative. Mycopathologia 99, 175–181 (1987). https://doi.org/10.1007/BF00437440
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00437440